Crossref journal-article
Elsevier BV
Cell (78)
Bibliography

Lang, G. A., Iwakuma, T., Suh, Y.-A., Liu, G., Rao, V. A., Parant, J. M., Valentin-Vega, Y. A., Terzian, T., Caldwell, L. C., Strong, L. C., El-Naggar, A. K., & Lozano, G. (2004). Gain of Function of a p53 Hot Spot Mutation in a Mouse Model of Li-Fraumeni Syndrome. Cell, 119(6), 861–872.

Authors 12
  1. Gene A. Lang (first)
  2. Tomoo Iwakuma (additional)
  3. Young-Ah Suh (additional)
  4. Geng Liu (additional)
  5. V.Ashutosh Rao (additional)
  6. John M. Parant (additional)
  7. Yasmine A. Valentin-Vega (additional)
  8. Tamara Terzian (additional)
  9. Lisa C. Caldwell (additional)
  10. Louise C. Strong (additional)
  11. Adel K. El-Naggar (additional)
  12. Guillermina Lozano (additional)
References 65 Referenced 895
  1. 10.1046/j.1432-1327.2001.02225.x / Eur. J. Biochem / Post-translational modifications and activation of p53 by genotoxic stresses by Appella (2001)
  2. 10.1073/pnas.2436329100 / Proc. Natl. Acad. Sci. USA / P53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1 by Asher (2003)
  3. {'key': '10.1016/j.cell.2004.11.006_BIB3', 'first-page': '1699', 'article-title': 'Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies', 'volume': '6', 'author': 'Bartek', 'year': '1991', 'journal-title': 'Oncogene'} / Oncogene / Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies by Bartek (1991)
  4. 10.1136/mp.56.5.286 / Mol. Pathol / Alterations in p53 predict response to preoperative high dose chemotherapy in patients with gastric cancer by Bataille (2003)
  5. 10.1002/humu.10172 / Hum. Mutat / TP53 family members and human cancers by Benard (2003)
  6. 10.1126/science.2274789 / Science / Genetic mechanisms of tumor suppression by the human p53 gene by Chen (1990)
  7. 10.1158/0008-5472.CAN-03-1060 / Cancer Res / Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo by Concin (2004)
  8. 10.1073/pnas.052713099 / Proc. Natl. Acad. Sci. USA / Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function by de Vries (2002)
  9. 10.1128/MCB.19.2.1438 / Mol. Cell. Biol / p73 function is inhibited by tumor-derived p53 mutants in mammalian cells by Di Como (1999)
  10. 10.1038/ng0593-42 / Nat. Genet / Gain of function mutations in p53 by Dittmer (1993)
  11. 10.1038/356215a0 / Nature / Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours by Donehower (1992)
  12. 10.1002/mc.2940140105 / Mol. Carcinog / Effects of genetic background on tumorigenesis in p53-deficient mice by Donehower (1995)
  13. 10.1016/S1357-4310(97)01105-2 / Mol. Med. Today / The Li-Fraumeni syndrome by Evans (1997)
  14. 10.1038/sj.onc.1204533 / Oncogene / An alternatively spliced HDM2 product increases p53 activity by inhibiting HDM2 by Evans (2001)
  15. 10.1038/358083a0 / Nature / Wild-type p53 activates transcription in vitro by Farmer (1992)
  16. 10.1038/sj.onc.1204118 / Oncogene / Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53 by Fillippovich (2001)
  17. 10.1128/MCB.8.2.531 / Mol. Cell. Biol / Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life by Finlay (1988)
  18. 10.1038/416560a / Nature / p63 and p73 are required for p53-dependent apoptosis in response to DNA damage by Flores (2002)
  19. 10.1128/MCB.18.7.3735 / Mol. Cell. Biol / Activation of c-myc gene expression by tumor-derived p53 mutants requires a discrete C-terminal domain by Frazier (1998)
  20. 10.1128/MCB.21.5.1874-1887.2001 / Mol. Cell. Biol / A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain by Gaiddon (2001)
  21. {'key': '10.1016/j.cell.2004.11.006_BIB21', 'first-page': '4855', 'article-title': 'Mutations in the p53 tumor suppressor gene', 'volume': '54', 'author': 'Greenblatt', 'year': '1994', 'journal-title': 'Cancer Res'} / Cancer Res / Mutations in the p53 tumor suppressor gene by Greenblatt (1994)
  22. 10.1038/ng1193-225 / Nat. Genet / Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice by Harvey (1993)
  23. {'key': '10.1016/j.cell.2004.11.006_BIB23', 'first-page': '2457', 'article-title': 'In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice', 'volume': '8', 'author': 'Harvey', 'year': '1993', 'journal-title': 'Oncogene'} / Oncogene / In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice by Harvey (1993)
  24. 10.1096/fasebj.7.10.8344491 / FASEB J / Genetic background alters the spectrum of tumors that develop in p53-deficient mice by Harvey (1993)
  25. 10.1128/JVI.63.2.739-746.1989 / J. Virol / Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation by Hinds (1989)
  26. {'key': '10.1016/j.cell.2004.11.006_BIB26', 'first-page': '571', 'article-title': 'Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells', 'volume': '1', 'author': 'Hinds', 'year': '1990', 'journal-title': 'Cell Growth Differ'} / Cell Growth Differ / Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells by Hinds (1990)
  27. 10.1086/374567 / Am. J. Hum. Genet / Germline p53 mutations in a cohort with childhood sarcoma by Hwang (2003)
  28. 10.1002/humu.10175 / Hum. Mutat / TP53 mutation in colorectal cancer by Iacopetta (2003)
  29. {'key': '10.1016/j.cell.2004.11.006_BIB29', 'first-page': '636', 'article-title': 'Possible oncogenic potential of DeltaNp73', 'volume': '62', 'author': 'Ishimoto', 'year': '2002', 'journal-title': 'Cancer Res'} / Cancer Res / Possible oncogenic potential of DeltaNp73 by Ishimoto (2002)
  30. {'key': '10.1016/j.cell.2004.11.006_BIB30', 'first-page': '993', 'article-title': 'MDM2, an introduction', 'volume': '1', 'author': 'Iwakuma', 'year': '2003', 'journal-title': 'Mol. Cancer Res'} / Mol. Cancer Res / MDM2, an introduction by Iwakuma (2003)
  31. 10.1038/sj.onc.1207793 / Oncogene / Mutation at p53 serine 389 does not rescue the embryonic lethality in mdm2 or mdm4 null mice by Iwakuma (2004)
  32. 10.1016/S0960-9822(00)00002-6 / Curr. Biol / Tumor spectrum analysis in p53-mutant mice by Jacks (1994)
  33. 10.1126/science.7878469 / Science / Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms by Jeffrey (1995)
  34. 10.1038/378206a0 / Nature / Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53 by Jones (1995)
  35. 10.1016/S0092-8674(00)80540-1 / Cell / Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers by Kaghad (1997)
  36. 10.1007/BF02255920 / J. Biomed. Sci / p53 gene status modulates the chemosensitivity of non-small cell lung cancer cells by Lai (2000)
  37. 10.1016/S1359-6446(03)02669-2 / Drug Discov. Today / Drug discovery and p53 by Lane (2003)
  38. 10.1146/annurev.bi.62.070193.003203 / Annu. Rev. Biochem / The tumor suppressor genes by Levine (1993)
  39. {'key': '10.1016/j.cell.2004.11.006_BIB39', 'first-page': '1365', 'article-title': 'Rhabdomyosarcoma in children', 'volume': '43', 'author': 'Li', 'year': '1969', 'journal-title': 'J. Natl. Cancer Inst'} / J. Natl. Cancer Inst / Rhabdomyosarcoma in children by Li (1969)
  40. 10.7326/0003-4819-71-4-747 / Ann. Intern. Med / Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? by Li (1969)
  41. {'key': '10.1016/j.cell.2004.11.006_BIB41', 'first-page': '5358', 'article-title': 'A cancer family syndrome in twenty-four kindreds', 'volume': '48', 'author': 'Li', 'year': '1988', 'journal-title': 'Cancer Res'} / Cancer Res / A cancer family syndrome in twenty-four kindreds by Li (1988)
  42. 10.1038/sj.onc.1201621 / Oncogene / A transgenic mouse model for mammary carcinogenesis by Li (1998)
  43. 10.1073/pnas.97.8.4174 / Proc. Natl. Acad. Sci. USA / High metastatic potential in mice inheriting a targeted p53 missense mutation by Liu (2000)
  44. 10.1038/ng1282 / Nat. Genet / Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice by Liu (2004)
  45. 10.1126/science.1978757 / Science / Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms by Malkin (1990)
  46. 10.1128/MCB.11.1.12 / Mol. Cell. Biol / Tumor suppressor p53 by Milner (1991)
  47. 10.1038/378203a0 / Nature / Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53 by Montes de Oca Luna (1995)
  48. 10.1016/j.cell.2004.11.004 / Cell / Mutant p53 gain-of-function in two mouse models of Li-Fraumeni syndrome by Olive (2004)
  49. {'key': '10.1016/j.cell.2004.11.006_BIB49', 'first-page': '443', 'article-title': 'Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer', 'volume': '6', 'author': 'Powell', 'year': '2000', 'journal-title': 'Clin. Cancer Res'} / Clin. Cancer Res / Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer by Powell (2000)
  50. 10.1038/sj.onc.1205704 / Oncogene / Novel gain of function activity of p53 mutants by Pugacheva (2002)
  51. {'key': '10.1016/j.cell.2004.11.006_BIB51', 'first-page': '6788', 'article-title': 'Oncogenic mutations of the p53 tumor suppressor', 'volume': '60', 'author': 'Sigal', 'year': '2000', 'journal-title': 'Cancer Res'} / Cancer Res / Oncogenic mutations of the p53 tumor suppressor by Sigal (2000)
  52. {'key': '10.1016/j.cell.2004.11.006_BIB52', 'first-page': '1031', 'article-title': 'p53 mutations in defined structural and functional domains are related to poor clinical outcome in non-small cell lung cancer patients', 'volume': '6', 'author': 'Skaug', 'year': '2000', 'journal-title': 'Clin. Cancer Res'} / Clin. Cancer Res / p53 mutations in defined structural and functional domains are related to poor clinical outcome in non-small cell lung cancer patients by Skaug (2000)
  53. 10.1002/j.1460-2075.1993.tb05744.x / EMBO J / The transforming and suppressor functions of p53 alleles by Slingerland (1993)
  54. 10.1016/S1535-6108(03)00081-3 / Cancer Cell / p53 mutations and resistance to chemotherapy by Soussi (2003)
  55. 10.1038/348747a0 / Nature / Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome by Srivastava (1990)
  56. 10.1074/jbc.M200480200 / J. Biol. Chem / Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding by Stiewe (2002)
  57. 10.1074/jbc.M201405200 / J. Biol. Chem / Physical interaction with human tumor-derived p53 mutants inhibits p63 activities by Strano (2002)
  58. {'key': '10.1016/j.cell.2004.11.006_BIB58', 'first-page': '1513', 'article-title': 'A C-terminal alpha-helix plus basic region motif is the major structural determinant of p53 tetramerization', 'volume': '7', 'author': 'Sturzbecher', 'year': '1992', 'journal-title': 'Oncogene'} / Oncogene / A C-terminal alpha-helix plus basic region motif is the major structural determinant of p53 tetramerization by Sturzbecher (1992)
  59. 10.1002/(SICI)1098-2744(199811)23:3<185::AID-MC7>3.0.CO;2-5 / Mol. Carcinog / Analysis of centrosome abnormalities and angiogenesis in epidermal- targeted p53172H mutant and p53-knockout mice after chemical carcinogenesis by Wang (1998)
  60. 10.1038/sj.onc.1201890 / Oncogene / Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesis by Wang (1998)
  61. 10.1016/S1097-2765(00)80275-0 / Mol. Cell / p63, a p53 homolog at 3q27–29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities by Yang (1998)
  62. 10.1038/19539 / Nature / p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development by Yang (1999)
  63. 10.1038/35003607 / Nature / p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours by Yang (2000)
  64. 10.1084/jem.20020179 / J. Exp. Med / DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors by Zaika (2002)
  65. 10.1006/excr.1999.4452 / Exp. Cell Res / Tumor radiosensitivity and apoptosis by Zhivotovsky (1999)
Dates
Type When
Created 20 years, 8 months ago (Dec. 17, 2004, 5:09 p.m.)
Deposited 5 years, 4 months ago (April 4, 2020, 4:32 p.m.)
Indexed 3 days, 3 hours ago (Aug. 21, 2025, 2:13 p.m.)
Issued 20 years, 8 months ago (Dec. 1, 2004)
Published 20 years, 8 months ago (Dec. 1, 2004)
Published Print 20 years, 8 months ago (Dec. 1, 2004)
Funders 0

None

@article{Lang_2004, title={Gain of Function of a p53 Hot Spot Mutation in a Mouse Model of Li-Fraumeni Syndrome}, volume={119}, ISSN={0092-8674}, url={http://dx.doi.org/10.1016/j.cell.2004.11.006}, DOI={10.1016/j.cell.2004.11.006}, number={6}, journal={Cell}, publisher={Elsevier BV}, author={Lang, Gene A. and Iwakuma, Tomoo and Suh, Young-Ah and Liu, Geng and Rao, V.Ashutosh and Parant, John M. and Valentin-Vega, Yasmine A. and Terzian, Tamara and Caldwell, Lisa C. and Strong, Louise C. and El-Naggar, Adel K. and Lozano, Guillermina}, year={2004}, month=dec, pages={861–872} }